Categories: AddictionNews

Ibogaine by David Dardashti Optimizes Algorithm for Fentanyl Treatment

Innovative Treatment Protocol Aims to Revolutionize Fentanyl Treatment

MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) — For those struggling with fentanyl addiction, Ibogaine by David Dardashti is revolutionizing the way the deadly opiate is treated.

Fentanyl Treatment

Ibogaine by David Dardashti has developed an optimized algorithm for fentanyl treatment that takes into account the individual’s prior use of the drug and any associated potency. This algorithm also accounts for any other drugs that the individual may be consuming, addressing drug interactions with opiates in a proactive manner. “By utilizing implicit differentiation, our algorithm is tailored specifically to the needs of each patient,” said David Dardashti. “This method allows us to adjust the algorithm based on the observations of previous operations, while taking into consideration the other substances the patient may be taking.” The algorithm adds additional days of treatment for those who are currently taking or who have recently taken fentanyl in combination with other opiates.

The algorithm has been designed to account for any potential future opiate use, and any associated potency, by using the same core components but adjusting one variable at a time. This innovative method is being used to drastically reduce the accessibility of and dependence on fentanyl, and to minimize the physical and psychological side effects associated with the highly potent drug. Ibogaine by David Dardashti hopes that this breakthrough algorithm will revolutionize drug treatment around the world.

For more information on Ibogaine by David Dardashti and their optimized algorithm for fentanyl treatment, please visit their website at www.ibogaineclinic.com.

CONTACT: Gavriel Dardashti
+17869301880
gavriel@ibogaineclinic.com

Staff

Recent Posts

Registration Opens for DeviceTalks West 2024

Why Did You Get into MedTech? Join us at DeviceTalks West to Learn from other…

39 mins ago

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting…

42 mins ago

GoCheck Kids Announces Partnership With hearX

Technology Leaders Partner to Develop First Smartphone-Based Combined Pediatric Vision and Hearing Screening SolutionNASHVILLE, TN…

42 mins ago

Qosina Welcomes New Representative in Germany and Benelux Region

RONKONKOMA, N.Y.--(BUSINESS WIRE)--#biopharma--Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical…

4 hours ago

Qosina Welcomes New Representative in Germany and Benelux Region

RONKONKOMA, N.Y.--(BUSINESS WIRE)--#biopharma--Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical…

4 hours ago